Skip to main content
    I

    ICL Israel Chemicals Ltd (ICL)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NYSE

    $4.41
    -0.11 (-2.54%)

    Market Cap: $6.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ICL Israel Chemicals Ltd (ICL) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    ICL Israel Chemicals reported revenue of $7.15B for the fiscal year ended Dec 31, 2025, up 4.6% from the year before. That year, net income was $226.00M with a net margin of 3.2%, operating cash flow was $954.00M and free cash flow was $130.00M. The quarter ended Sep 30, 2026 had revenue of $1.91B and net income of $120.00M.

    Revenue and Margins

    The operating margin was 9.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $5.36B, a compound annual rate of 3.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$7.15B+4.6%30.6%9.8%3.2%
    Dec 2024$6.84B-9.2%33.0%11.3%5.9%
    Dec 2023$7.54B-24.8%35.4%15.1%8.6%
    Dec 2022$10.02B+44.0%50.2%35.1%21.6%
    Dec 2021$6.96B+37.9%37.5%17.4%11.3%
    Dec 2020$5.04B-4.3%29.5%4.0%0.2%
    Dec 2019$5.27B-5.1%34.5%14.3%9.0%
    Dec 2018$5.56B+2.5%33.4%27.3%22.3%
    Dec 2017$5.42B+1.0%30.9%11.6%6.7%
    Dec 2016$5.36BN/A31.0%-0.1%-2.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 44.5% from the year before. In the quarter ended Sep 2026, net income rose 4.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$7.15B$6.84B$7.54B$10.02B$6.96B$5.04B$5.27B$5.56B$5.42B$5.36B
    Cost of revenue$4.97B$4.58B$4.87B$4.98B$4.34B$3.55B$3.45B$3.70B$3.75B$3.70B
    Gross profit$2.19B$2.26B$2.67B$5.03B$2.61B$1.49B$1.82B$1.85B$1.67B$1.66B
    Research and development$70.00M$69.00M$71.00M$68.00M$64.00M$54.00M$50.00M$55.00M$55.00M$73.00M
    Operating income$703.00M$775.00M$1.14B$3.52B$1.21B$202.00M$756.00M$1.52B$629.00M-$3.00M
    Net income$226.00M$407.00M$647.00M$2.16B$783.00M$11.00M$475.00M$1.24B$364.00M-$122.00M
    EBITDA$1.35B$1.38B$1.67B$4.04B$1.69B$634.00M$1.18B$1.98B$992.00M$413.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.91B$2.13B$2.02B$1.70B$1.85B$1.83B$1.77B$1.60B$1.75B$1.75B$1.74B$1.69B
    Gross profit$628.00M$664.00M$626.00M$468.00M$604.00M$554.00M$560.00M$535.00M$596.00M$568.00M$557.00M$560.00M
    Operating income$230.00M$267.00M$235.00M$99.00M$230.00M$189.00M$185.00M$147.00M$214.00M$211.00M$203.00M$149.00M
    Net income$120.00M$137.00M$126.00M-$73.00M$115.00M$93.00M$91.00M$70.00M$113.00M$115.00M$109.00M$67.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.58B exceeded cash and equivalents by $2.29B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$12.41B$11.32B$11.63B$11.75B$11.08B$9.66B$9.17B$8.75B$8.71B$8.55B
    Current assets$4.16B$3.59B$4.03B$4.55B$3.91B$2.84B$2.68B$2.76B$2.73B$2.57B
    Cash and equivalents$291.00M$327.00M$420.00M$417.00M$473.00M$214.00M$95.00M$121.00M$83.00M$87.00M
    Total liabilities$6.17B$5.33B$5.59B$6.04B$6.34B$5.58B$5.11B$4.83B$5.78B$5.89B
    Short-term debt$876.00M$384.00M$858.00M$512.00M$577.00M$679.00M$420.00M$610.00M$822.00M$588.00M
    Long-term debt$1.70B$1.72B$1.63B$2.31B$2.44B$2.09B$2.18B$1.81B$2.39B$2.80B
    Shareholder equity$5.98B$5.72B$5.77B$5.46B$4.53B$3.93B$3.92B$3.78B$2.86B$2.57B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$13.28B$13.19B$13.01B$12.41B$12.26B$12.38B$11.69B$11.32B$11.56B$11.21B$11.49B$11.63B
    Total liabilities$6.75B$6.75B$6.68B$6.17B$5.88B$6.11B$5.57B$5.33B$5.42B$5.22B$5.44B$5.59B
    Cash and equivalents$494.00M$496.00M$407.00M$291.00M$356.00M$582.00M$312.00M$327.00M$393.00M$287.00M$363.00M$420.00M
    Shareholder equity$6.22B$6.15B$6.05B$5.98B$6.13B$6.01B$5.84B$5.72B$5.87B$5.75B$5.76B$5.77B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 13.6% of operating cash flow. Dividends came to 172.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$954.00M$1.36B$1.59B$2.02B$1.06B$804.00M$992.00M$620.00M$847.00M$966.00M
    Capital expenditures$824.00M$713.00M$780.00M$747.00M$611.00M$626.00M$576.00M$572.00M$457.00M$632.00M
    Free cash flow$130.00M$650.00M$815.00M$1.28B$454.00M$178.00M$416.00M$48.00M$390.00M$334.00M
    Dividends paid$224.00M$308.00M$489.00M$1.17B$276.00M$118.00M$273.00M$241.00M$237.00M$162.00M
    Investing cash flow-$930.00M-$711.00M-$863.00M-$754.00M-$579.00M-$583.00M-$525.00M$331.00M-$333.00M-$800.00M
    Financing cash flow-$78.00M-$724.00M-$712.00M-$1.30B-$244.00M-$105.00M-$490.00M-$894.00M-$511.00M-$239.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$256.00M$290.00M$180.00M$300.79M$308.00M$269.00M$165.00M$415.55M$408.00M$316.00M$292.00M$415.00M
    Capital expenditures$190.00M$197.00M$135.00M$275.84M$180.00M$202.00M$190.00M$268.66M$159.00M$142.00M$145.00M$255.00M
    Free cash flow$66.00M$93.00M$45.00M$24.95M$128.00M$67.00M-$25.00M$146.89M$249.00M$174.00M$147.00M$160.00M
    Last 12 quarters

    Frequently Asked Questions About ICL

    What is ICL Israel Chemicals' annual revenue?

    ICL Israel Chemicals reported revenue of $7.15B for the fiscal year ended Dec 31, 2025.

    How fast is ICL Israel Chemicals' revenue growing?

    Revenue was up 4.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -10.6%.

    Is ICL Israel Chemicals profitable?

    Yes. ICL Israel Chemicals reported net income of $226.00M for the fiscal year ended Dec 31, 2025, with a net margin of 3.2%.

    How much free cash flow does ICL generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $954.00M minus capital expenditures of $824.00M produced free cash flow of $130.00M.

    How much debt does ICL Israel Chemicals have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.70B, short-term debt of $876.00M and cash and equivalents of $291.00M.